Brief: Oncternal Therapeutics Q2 Net Income USD -8.559 Million
08/08/2024 21:01
Aug 08 (Reuters) - Oncternal Therapeutics Q2 basic EPS USD -2.89. * Q2 income from operations USD -8.863 million * Q2 operating expenses USD 9.664 million
Recent news on Oncternal Therapeutics
See all newsOncternal Therapeutics Inc expected to post a loss of $3.19 a share - Earnings Preview
Brief: Oncternal Therapeutics Workforce Reduction Of About 10 Employees
U.S. STOCKS ON THE MOVE-Unity Software, Viking Holdings, Adobe
U.S. STOCKS ON THE MOVE-Gold miners, silver miners, Warner Bros Discovery
Oncternal hits record low on plans to scrap studies, explore strategic alternatives;